BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37047218)

  • 21. Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.
    Deep G; Gangar SC; Oberlies NH; Kroll DJ; Agarwal R
    Mol Carcinog; 2010 Oct; 49(10):902-12. PubMed ID: 20721970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential CARM1 expression in prostate and colorectal cancers.
    Kim YR; Lee BK; Park RY; Nguyen NT; Bae JA; Kwon DD; Jung C
    BMC Cancer; 2010 May; 10():197. PubMed ID: 20462455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3.
    Miao L; Yun X; Tao R; Wang Y; Fan G; Zhu Y; Cai T; Zhu Z; Yan C; Gao X
    J Pharmacol Sci; 2018 Sep; 138(1):1-8. PubMed ID: 30236540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.
    Lamb LE; Zarif JC; Miranti CK
    Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.
    Samykutty A; Shetty AV; Dakshinamoorthy G; Bartik MM; Johnson GL; Webb B; Zheng G; Chen A; Kalyanasundaram R; Munirathinam G
    PLoS One; 2013; 8(6):e65889. PubMed ID: 23824300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kappaB regulates androgen receptor expression and prostate cancer growth.
    Zhang L; Altuwaijri S; Deng F; Chen L; Lal P; Bhanot UK; Korets R; Wenske S; Lilja HG; Chang C; Scher HI; Gerald WL
    Am J Pathol; 2009 Aug; 175(2):489-99. PubMed ID: 19628766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
    Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
    Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
    Kollara A; Diamandis EP; Brown TJ
    J Steroid Biochem Mol Biol; 2003 Apr; 84(5):493-502. PubMed ID: 12767274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.
    Nadiminty N; Lou W; Sun M; Chen J; Yue J; Kung HJ; Evans CP; Zhou Q; Gao AC
    Cancer Res; 2010 Apr; 70(8):3309-19. PubMed ID: 20388792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
    Lee SO; Lou W; Nadiminty N; Lin X; Gao AC
    Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
    Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
    Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA binding alters ARv7 dimer interactions.
    Özgün F; Kaya Z; Morova T; Geverts B; Abraham TE; Houtsmuller AB; van Royen ME; Lack NA
    J Cell Sci; 2021 Jul; 134(14):. PubMed ID: 34318896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
    Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.